一、公司业绩表现强劲京东健康(06618)在截至去年12月底的全年业绩中表现出色，第四季度收入同比增长27%，超出市场预期4%。调整后营业利益同比增长246%，与预期相符，而调整后净利润增长30%，优于其他收入指标。尽管如此，摩根士丹利预计今年净利润可能持平。基于此，大摩给予京东健康目标价70港元，并“与大市同步”的评级。二、管理层对业务护城河的信心京东健康管理层认为，公司在严格履约标准的药品领域...
Source Link一、公司业绩表现强劲京东健康(06618)在截至去年12月底的全年业绩中表现出色，第四季度收入同比增长27%，超出市场预期4%。调整后营业利益同比增长246%，与预期相符，而调整后净利润增长30%，优于其他收入指标。尽管如此，摩根士丹利预计今年净利润可能持平。基于此，大摩给予京东健康目标价70港元，并“与大市同步”的评级。二、管理层对业务护城河的信心京东健康管理层认为，公司在严格履约标准的药品领域...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.